Insider Trading February 19, 2026

Saba Capital Increases Stake in Virtus Dividend Fund with $8,310 Purchase

600 NFJ shares bought at $13.85; filing shows Saba now holds nearly 9.87 million shares

By Derek Hwang NFJ
Saba Capital Increases Stake in Virtus Dividend Fund with $8,310 Purchase
NFJ

Saba Capital Management, L.P., a 10% holder of Virtus Dividend, Interest & Premium Strategy Fund (NYSE: NFJ), purchased 600 shares on February 18, 2026 at $13.85 per share for a total of $8,310. A subsequent Form 4 filing shows the firm directly holds 9,869,469 shares. The fund has returned 17.79% over the past year and carries a "GOOD" overall financial health score.

Key Points

  • Saba Capital Management, L.P. purchased 600 shares of Virtus Dividend, Interest & Premium Strategy Fund (NFJ) on February 18, 2026 for $13.85 per share, totaling $8,310.
  • Following the purchase, Saba Capital directly holds 9,869,469 shares of NFJ and is noted as a ten-percent owner.
  • NFJ reported a 17.79% total return over the past year and carries an overall financial health score of "GOOD"; InvestingPro offers six additional investment tips and multiple financial metrics for the fund.

Saba Capital Management, L.P. added to its position in Virtus Dividend, Interest & Premium Strategy Fund (NYSE: NFJ) on February 18, 2026, acquiring 600 shares of the fund's common stock at a per-share price of $13.85. The block purchase amounted to $8,310 in total.

According to a Form 4 filing with the Securities and Exchange Commission, completed following the trade, Saba Capital now directly owns 9,869,469 shares of NFJ. The filing records the transaction and bears signatures indicating it was submitted on February 19, 2026. The document was signed by Zachary Gindes on behalf of Saba Capital Management, L.P., and also signed by Boaz Weinstein.

The filing identifies Saba Capital as a ten-percent owner of the Virtus Dividend, Interest & Premium Strategy Fund. The reported purchase is a modest increment relative to the firm's aggregate holding but is formally recorded in the public disclosure required for insiders and significant shareholders.

Performance metrics included in the disclosure note that NFJ has produced a 17.79% total return over the last twelve months. Separately, the fund is assigned an overall financial health score of "GOOD." Additional investment resources for NFJ are available through InvestingPro, which the filing notes offers six additional investment tips and dozens more financial metrics to inform investors.


Context and disclosure

The transaction details in the Form 4 provide the precise price, share count, and timing of the purchase. The filing reflects the signatures and the date of submission to the SEC, but it does not include commentary from Saba Capital or fund management regarding motivation or future plans.

This report is limited to the information contained in the SEC filing and the fund performance and health metrics referenced. No further assertions about intent or prospective performance are made beyond the stated facts.

Risks

  • The SEC Form 4 filing documents the transaction but does not disclose Saba Capital's investment rationale or future intentions - this limits insight into motive and strategy.
  • The reported purchase is small in dollar terms relative to the aggregate holding, so its informational significance about shareholder conviction is limited.
  • Performance figures and the financial health score are historical and descriptive; they do not guarantee future returns or performance for NFJ.

More from Insider Trading

Sonoco Packaging Executive Disposes Small Stake as Company Outlines Multi-Year Earnings Goals Feb 20, 2026 Bank of the James Director Adds $20,412 in Shares; Co-Founder Retires After Long Tenure Feb 20, 2026 Rogers Corp Director Disposes of 8,000 Shares; Stock Near Yearly High After Strong Quarter Feb 20, 2026 Nicolet Bankshares Director Executes Stock Sales and Option Exercise Totaling Over $2 Million Feb 20, 2026 CME Group Director Disposes $91,770 in Shares as Company Advances New Products Feb 20, 2026